Ethical Implications of the Cost of Molecularly Targeted Therapies

被引:7
|
作者
Flotte, Terence R.
机构
关键词
D O I
10.1089/hum.2015.29010.trf
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:573 / 574
页数:2
相关论文
共 50 条
  • [1] Molecularly targeted therapies for melanoma
    Liu, Lucinda S.
    Colegio, Oscar R.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2013, 52 (05) : 523 - 530
  • [2] Molecularly Targeted Therapies for Glioma
    Yamanaka, Ryuya
    Saya, Hideyuki
    ANNALS OF NEUROLOGY, 2009, 66 (06) : 717 - 729
  • [3] DISCOVERY OF MOLECULARLY TARGETED THERAPIES
    Regan, Kelly
    Abrams, Zachary
    Sharpnack, Michael
    Srivastava, Arunima
    Huang, Kun
    Shah, Nigam
    Payne, Philip R. O.
    PACIFIC SYMPOSIUM ON BIOCOMPUTING 2016, 2016, : 1 - 8
  • [4] Resistance to Molecularly Targeted Therapies in Melanoma
    Patel, Meet
    Eckburg, Adam
    Gantiwala, Shahina
    Hart, Zachary
    Dein, Joshua
    Lam, Katie
    Puri, Neelu
    CANCERS, 2021, 13 (05) : 1 - 26
  • [5] Molecularly targeted cancer therapies: Into the future
    Lewis, LD
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (11) : A215 - A215
  • [6] Molecularly Targeted Therapies for Dysimmune Neuropathies
    Andreas A. Argyriou
    Molecular Medicine, 2009, 15 : 283 - 287
  • [7] Molecularly Targeted Therapies for Malignant Gliomas
    Andreas A. Argyriou
    Haralabos P. Kalofonos
    Molecular Medicine, 2009, 15 : 115 - 122
  • [8] Molecularly Targeted Therapies for Malignant Gliomas
    Argyriou, Andreas A.
    Kalofonos, Haralabos P.
    MOLECULAR MEDICINE, 2009, 15 (3-4) : 115 - 122
  • [9] Molecularly Targeted Therapies for Dysimmune Neuropathies
    Argyriou, Andreas A.
    MOLECULAR MEDICINE, 2009, 15 (7-8) : 283 - 287
  • [10] MOLECULARLY TARGETED THERAPIES FOR THYROID CANCERS
    Sherman, Steven I.
    ENDOCRINE PRACTICE, 2009, 15 (06) : 605 - 611